Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx 2021-10-15 12:00
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results. 2021-10-15 05:26
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA) 2021-10-14 20:46
Roan Holdings Group Announces Agreement to Set Up Joint Venture to Expand in Consumer Health Services Market 2021-10-14 20:00
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms 2021-10-14 19:30
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
21 Swiss Startups to take the Stage at China's Hottest Tech Expos 2021-10-14 16:18
A China-developed COVID-19 vaccine is conducting clinical trial in Philippines 2021-10-14 12:58
Restart-A-Heart Day - Targets Aussie Women 2021-10-14 09:15
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year 2021-10-13 22:07
One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows 2021-10-13 20:30
Gannex Announces Clinical and Preclinical Data of Four NASH Programs to be Presented in Oral or Poster Presentation at The Liver Meeting® 2021 by American Association for the Study of Liver Diseases 2021-10-13 20:30
Berry Oncology Releases Latest Research Results on Early Screening for Multiple Cancers 2021-10-13 20:20
Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt 2021-10-13 20:00
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
Shanghai, industry partners to co-build world-class biopharma industry cluster 2021-10-13 19:43
The CDE Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-10-13 15:47
World Thrombosis Day Campaign Unites Thousands of Global Partners to Shine a Spotlight on Blood Clots as an Urgent Health Problem 2021-10-13 14:19
Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America 2021-10-13 13:00
1 330 331 332 333 334 891